Zydus to launch Semaglutide Injection in India on patent expiry

Zydus to launch Semaglutide Injection in India on patent expiry

Zydus to launch Semaglutide Injection in India, featuring a unique reusable pen for improved diabetes and obesity management.

Zydus Lifesciences is set to launch Semaglutide Injection in India upon patent expiry, bringing a novel, patient-friendly therapy for Type 2 Diabetes and Obesity. The drug features an adjustable, reu… [+1847 chars]
Zydus to launch Semaglutide Injection in India on patent expiry - FHMnews